Thomas (Tucker) Kelly
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas (Tucker) Kelly
Thomas (Tucker) Kelly is recorded as CFO at Xenon Pharmaceuticals Inc. (XENE). Xenon Pharmaceuticals Inc. reported in an 8-K filed October 16, 2025 that Thomas (Tucker) Kelly was appointed Chief Financial Officer, effective October 15, 2025. Thomas (Tucker) Kelly has spoken on 1 earnings call across 1 company, most recently for Xenon Pharmaceuticals Inc. on May 7, 2026.
“On October 16, 2025, Xenon Pharmaceuticals Inc. (the "Company") announced that Thomas (Tucker) Kelly has been appointed to serve as the Company's Chief Financial Officer, effective October 15, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-10-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Xenon Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Ian Mortimer CEO, Chief Accounting Officer, Board Member
- Simon Pimstone Chairman
- Thomas Kelly CFO
- Tucker Kelly CFO
- Clarissa Desjardins Board Member
- Dawn Svoronos Board Member
- Dr. Clarissa Desjardins Board Member
- Dr. Gillian Cannon Board Member
- Elizabeth Garofalo Board Member
- Frank Holler Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.